Brain AG plans IPO on Frankfurt stock exchange
Now further growth will be financed through the stock exchange. The bioeconomy pioneers from Zwingenberg had speculated on a possible floatation for a long time, and now it’s definite. On 5th January, Brain AG officially announced their IPO plans and in contrast to many other German biotech companies, have decided to float on the Frankfurt stock exchange. “We see ourselves as an icebreaker for the bioeconomy in the financial centre Frankfurt,” CEO Jürgen Eck emphasises to biotechnologie.de.